Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Wilschut JC"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-17 z 17
    Tytuł:
    Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.
    Autorzy:
    Tu HAT (AUTHOR)
    Bos JHJ (AUTHOR)
    Woerdenbag HJ (AUTHOR)
    Visser ST (AUTHOR)
    Wilschut JC (AUTHOR)
    van Assen S (AUTHOR)
    de Jong-van den Berg LTW (AUTHOR)
    Postma MJ (AUTHOR)
    Pokaż więcej
    Źródło:
    Clinical Therapeutics. Jan2010, Vol. 32 Issue 1, p133-144. 12p.
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach.
    Autorzy:
    Zeevat F; University Medical Center Groningen, Groningen, The Netherlands.; Health-Ecore, Zeist, The Netherlands.
    Simons JJM; University Medical Center Groningen, Groningen, The Netherlands. .; GSK, Amersfoort, The Netherlands. .; Market Access Department, GSK, Van Ash van Wijckstraat 55H, 3811, Amersfoort, The Netherlands. .
    Westra TA; GSK, Amersfoort, The Netherlands.
    Wilschut JC; University Medical Center Groningen, Groningen, The Netherlands.
    van Sorge NM; Amsterdam University Medical Center, Amsterdam, The Netherlands.
    Boersma C; University Medical Center Groningen, Groningen, The Netherlands.; Health-Ecore, Zeist, The Netherlands.; Open University, Heerlen, The Netherlands.
    Postma MJ; University Medical Center Groningen, Groningen, The Netherlands.
    Pokaż więcej
    Źródło:
    Infectious diseases and therapy [Infect Dis Ther] 2024 Mar; Vol. 13 (3), pp. 481-499. Date of Electronic Publication: 2024 Feb 16.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Viral causes of severe acute respiratory infection in hospitalized children and association with outcomes: A two-year prospective surveillance study in Suriname.
    Autorzy:
    Juliana AE; Department of Pediatrics, Academic Pediatric Center Suriname, Academic Hospital Paramaribo, Paramaribo, Suriname.
    Tang MJ; Department of Pediatrics, Academic Pediatric Center Suriname, Academic Hospital Paramaribo, Paramaribo, Suriname.
    Kemps L; Department of Pediatrics, Academic Pediatric Center Suriname, Academic Hospital Paramaribo, Paramaribo, Suriname.
    Noort AC; Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands.
    Hermelijn S; Department of Medical Microbiology, Academic Hospital Paramaribo, Paramaribo, Suriname.
    Plötz FB; Department of Pediatrics, Tergooi Hospitals, Blaricum, The Netherlands.; Department of Pediatrics, Amsterdam UMC, Amsterdam, The Netherlands.
    Zonneveld R; Department of Pediatrics, Academic Pediatric Center Suriname, Academic Hospital Paramaribo, Paramaribo, Suriname.
    Wilschut JC; Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2021 Feb 19; Vol. 16 (2), pp. e0247000. Date of Electronic Publication: 2021 Feb 19 (Print Publication: 2021).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Epidemiological Monitoring*
    Hospitalization/*statistics & numerical data
    Respiratory Tract Infections/*therapy
    Respiratory Tract Infections/*virology
    Acute Disease/epidemiology ; Child ; Child, Preschool ; Humans ; Infant ; Male ; Multiplex Polymerase Chain Reaction ; Respiratory Tract Infections/epidemiology ; Suriname/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines.
    Autorzy:
    Wondimu A; Department of Pharmaceutics, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. .; Department of Health Sciences, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands. .
    Cao Q; Unit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.
    Wilschut JC; Department of Medical Microbiology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands.
    Postma MJ; Unit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.; Department of Health Sciences, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands.; Department of Economics, Econometrics & Finance, Faculty of Economics & Business, University of Groningen, Groningen, The Netherlands.
    Pokaż więcej
    Źródło:
    BMC public health [BMC Public Health] 2019 Dec 10; Vol. 19 (1), pp. 1656. Date of Electronic Publication: 2019 Dec 10.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Pneumococcal Vaccines/*administration & dosage
    Rotavirus Vaccines/*administration & dosage
    Vaccination/*statistics & numerical data
    Demography ; Ethiopia ; Female ; Humans ; Immunization Schedule ; Infant ; Male ; Socioeconomic Factors ; Vaccines, Conjugate/administration & dosage
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines.
    Autorzy:
    de Boer PT; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands. .; Unit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands. .
    van Lier A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
    de Melker H; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
    van Wijck AJM; Pain Clinic, University Medical Centre Utrecht, Utrecht, The Netherlands.
    Wilschut JC; Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
    van Hoek AJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
    Postma MJ; Unit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands.; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Economics, Econometrics & Finance, University of Groningen, Faculty of Economics & Business, Groningen, The Netherlands.
    Pokaż więcej
    Źródło:
    BMC medicine [BMC Med] 2018 Dec 06; Vol. 16 (1), pp. 228. Date of Electronic Publication: 2018 Dec 06.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Adjuvants, Immunologic/*economics
    Cost-Benefit Analysis/*methods
    Herpes Zoster/*drug therapy
    Herpes Zoster Vaccine/*economics
    Vaccines, Attenuated/*economics
    Adjuvants, Immunologic/pharmacology ; Adjuvants, Immunologic/therapeutic use ; Aged ; Aged, 80 and over ; Female ; Herpes Zoster Vaccine/pharmacology ; Herpes Zoster Vaccine/therapeutic use ; Humans ; Male ; Middle Aged ; Netherlands ; Quality of Life ; Vaccines, Attenuated/pharmacology ; Vaccines, Attenuated/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic Approach.
    Autorzy:
    Setiawan D; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.; Faculty of Pharmacy, University of Muhammadiyah Purwokerto, Purwokerto, Indonesia.
    Kotsopoulos N; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.; Global Market Access Solutions (GMAS), St-Prex, Switzerland.
    Wilschut JC; Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
    Postma MJ; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.; Institute of Science in Healthy Aging & healthcaRE (SHARE), University Medical Center Groningen (UMCG), Groningen, The Netherlands.
    Connolly MP; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.; Global Market Access Solutions (GMAS), St-Prex, Switzerland.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Aug 04; Vol. 11 (8), pp. e0160707. Date of Electronic Publication: 2016 Aug 04 (Print Publication: 2016).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Government Programs/*economics
    Papillomavirus Infections/*prevention & control
    Papillomavirus Vaccines/*immunology
    Uterine Cervical Neoplasms/*diagnosis
    Child ; Cost-Benefit Analysis ; Early Detection of Cancer/economics ; Female ; Humans ; Indonesia/epidemiology ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/mortality ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/mortality
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents.
    Autorzy:
    Gefenaite G; Department of Pharmacy, Pharmacoepidemiology & Pharmacoeconomics (PE2), University of Groningen, Groningen, the Netherlands. />Smit M
    Nijman HW
    Tami A
    Drijfhout IH
    Pascal A
    Postma MJ
    Wolters BA
    van Delden JJ
    Wilschut JC
    Hak E
    Pokaż więcej
    Źródło:
    BMC public health [BMC Public Health] 2012 Jul 02; Vol. 12, pp. 498. Date of Electronic Publication: 2012 Jul 02.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Immunization Programs/*statistics & numerical data
    Papillomavirus Infections/*prevention & control
    Papillomavirus Vaccines/*administration & dosage
    Parents/*psychology
    Patient Acceptance of Health Care/*statistics & numerical data
    Vaccination/*statistics & numerical data
    Adolescent ; Adult ; Female ; Humans ; Male ; Middle Aged ; Netherlands ; Program Evaluation ; Surveys and Questionnaires
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.
    Autorzy:
    Rozenbaum MH; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands. />Mangen MJ
    Giaquinto C
    Wilschut JC
    Hak E
    Postma MJ
    Pokaż więcej
    Corporate Authors:
    Consensus Group on Dutch Rotavirus Vaccination (CoRoVa-Group)
    Źródło:
    BMC public health [BMC Public Health] 2011 Jun 10; Vol. 11, pp. 462. Date of Electronic Publication: 2011 Jun 10.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Gastroenteritis/*prevention & control
    Immunization Programs/*economics
    Rotavirus/*immunology
    Rotavirus Infections/*prevention & control
    Rotavirus Vaccines/*economics
    Child, Preschool ; Consensus ; Cost-Benefit Analysis ; Gastroenteritis/virology ; Humans ; Netherlands ; Rotavirus Infections/economics ; Rotavirus Vaccines/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-17 z 17

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies